Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Quantum Genesis AI (QTZM) Other Operating Expenses (2016 - 2026)

Quantumzyme's Other Operating Expenses history spans 7 years, with the latest figure at -$18029.0 for Q1 2026.

  • For Q1 2026, Other Operating Expenses fell 185.05% year-over-year to -$18029.0; the TTM value through Jan 2026 reached $5065.0, down 94.42%, while the annual FY2025 figure was $162408.0, 23.16% up from the prior year.
  • Other Operating Expenses reached -$18029.0 in Q1 2026 per QTZM's latest filing, down from $23094.0 in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $59357.0 in Q4 2024 to a low of -$18029.0 in Q1 2026.
  • Average Other Operating Expenses over 3 years is $21405.2, with a median of $22146.5 recorded in 2025.
  • Peak YoY movement for Other Operating Expenses: plummeted 61.09% in 2025, then plummeted 185.05% in 2026.
  • A 3-year view of Other Operating Expenses shows it stood at $59357.0 in 2024, then tumbled by 61.09% to $23094.0 in 2025, then tumbled by 178.07% to -$18029.0 in 2026.
  • Per Business Quant, the three most recent readings for QTZM's Other Operating Expenses are -$18029.0 (Q1 2026), $23094.0 (Q4 2025), and $21199.0 (Q1 2025).